Page last updated: 2024-08-24

lamivudine and Fatigue

lamivudine has been researched along with Fatigue in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Jianwei, L; Menghua, W; Qinwei, Y; Xin, Z; Yu, Z	1
Drosu, NC; Edelman, ER; Housman, DE	1
Chen, J; DiNubile, MJ; Fischl, MA; Harvey, CM; Hirsch, MS; Hirschel, B; Leavitt, RY; McMahon, D; Squires, K; Staszewski, S; Steigbigel, RT	1

Trials

1 trial(s) available for lamivudine and Fatigue

Article	Year
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Oct-15, Volume: 37, Issue:8 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; RNA, Viral; Zidovudine	2003

Article

Year

Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Oct-15, Volume: 37, Issue:8

Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; RNA, Viral; Zidovudine

2003

Other Studies

2 other study(ies) available for lamivudine and Fatigue

Article	Year
Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4 AIDS research and therapy, 2020, 07-23, Volume: 17, Issue:1 Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Betacoronavirus; C-Reactive Protein; CD4 Lymphocyte Count; Chills; Coronavirus Infections; COVID-19; Cyclopropanes; Fatigue; Female; Fever; HIV; HIV Infections; Humans; Immunocompromised Host; Immunoglobulin M; Lamivudine; Middle Aged; Pandemics; Pharyngitis; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sputum; Time Factors; Tomography, X-Ray Computed; Virus Shedding; Zidovudine	2020
Could antiretrovirals be treating EBV in MS? A case report. Multiple sclerosis and related disorders, 2018, Volume: 22 Topics: Adult; Brain; Drug Combinations; Epstein-Barr Virus Infections; Fatigue; Female; Humans; Immunologic Factors; Lamivudine; Multiple Sclerosis, Relapsing-Remitting; Reverse Transcriptase Inhibitors; Zidovudine	2018

Article

Year

Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4

AIDS research and therapy, 2020, 07-23, Volume: 17, Issue:1

Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Betacoronavirus; C-Reactive Protein; CD4 Lymphocyte Count; Chills; Coronavirus Infections; COVID-19; Cyclopropanes; Fatigue; Female; Fever; HIV; HIV Infections; Humans; Immunocompromised Host; Immunoglobulin M; Lamivudine; Middle Aged; Pandemics; Pharyngitis; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sputum; Time Factors; Tomography, X-Ray Computed; Virus Shedding; Zidovudine

2020

Could antiretrovirals be treating EBV in MS? A case report.

Multiple sclerosis and related disorders, 2018, Volume: 22

Topics: Adult; Brain; Drug Combinations; Epstein-Barr Virus Infections; Fatigue; Female; Humans; Immunologic Factors; Lamivudine; Multiple Sclerosis, Relapsing-Remitting; Reverse Transcriptase Inhibitors; Zidovudine

2018